MARATTO

article · International Health

Does persistent active trachoma mandate antibiotic mass drug administration? A comparison of prevalence of trachomatous inflammation–follicular with that of conjunctival infection and anti-chlamydial antibodies, Western Province, Zambia

2025Open accessLusaka Apex Medical University

Abstract

Based on TF prevalence, this population qualified for additional antibiotic mass drug administration rounds, but PCR and serology-more specific indicators of current or recent C. trachomatis infection than TF-confirmed an absence of significant current community C. trachomatis transmission, allowing a transition to surveillance. Adding these indicators is helpful in persistent active trachoma.

Research topics

  • Reproductive tract infections research
  • Syphilis Diagnosis and Treatment
  • Bacterial Infections and Vaccines

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

View on publisher siteRecord on OpenAlex

DOI: 10.1093/inthealth/ihaf092

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.

Sign in to join the discussion

New to MARATTO™? Create a free account.